第 1 到 28 筆結果,共 28 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases | Cheng, Pin-Nan; WEN-JONE CHEN ; Hou, Charles Jia-Yin; Lin, Chih-Lin; Chang, Ming-Ling; Wang, Chia-Chi; Chang, Wei-Ting; Wang, Chao-Yung; Lin, Chun-Yen; Hung, Chung-Lieh; Peng, Cheng-Yuan; Yu, Ming-Lung; Chao, Ting-Hsing; Huang, Jee-Fu; Huang, Yi-Hsiang; Chen, Chi-Yi; Chiang, Chern-En; Lin, Han-Chieh; Li, Yi-Heng; TSUNG-HSIEN LIN ; JIA-HORNG KAO ; TZUNG-DAU WANG ; Liu, Ping-Yen; YEN-WEN WU ; CHUN-JEN LIU | Clinical and molecular hepatology | 1 | ||
2 | 2023 | Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective | TUNG-HUNG SU ; CHIH-HORNG WU ; TSUNG-HAO LIU ; CHENG-MAW HO ; CHUN-JEN LIU | Clinical and molecular hepatology | 8 | 6 | |
3 | 2022 | Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV | CHUN-JEN LIU ; PEI-JER CHEN | Liver International | 12 | 9 | |
4 | 2022 | Advancing the global public health agenda for NAFLD: a consensus statement | Lazarus J.V.; Mark H.E.; Anstee Q.M.; Arab J.P.; Batterham R.L.; Castera L.; Cortez-Pinto H.; Crespo J.; Cusi K.; Dirac M.A.; Francque S.; Hickman I.J.; Hocking S.L.; Hunyady B.; Idilman R.; Isakov V.A.; Jamal M.H.; Jepsen P.; Iskandar N.J.; Song M.J.; Sudhamshu K.C.; George J.; Kakizaki S.; Kalamitsis G.; Kanwal F.; JIA-HORNG KAO ; Kaplan L.; Kawaguchi T.; Khader Y.; Kim S.U.; Kodjoh N.; Koek G.; Hagström H.; Koike K.; Komas N.P.; Korenjak M.; Kugelmas M.; Labidi A.; Lange N.F.; Lavine J.E.; Lazo M.; Lee N.; Lesmana C.R.A.; Huang T.T.-K.; CHUN-JEN LIU ; Long M.T.; Lopez-Jaramillo P.; Malekzadeh R.; Mahtab M.A.; Marchesini G.; Marinho R.; Vázquez S.E.M.; Mateva L.; Nlombi C.M.; Ismail M.H.; Melin P.; Mikolasevic I.; Milovanovic T.; Musso C.; Nakajima A.; Nava E.; Nersesov A.V.; Nikolova D.; Norris S.; Novak K.; Kautz A.; Oben J.; Ong J.P.; Onyekwere C.; Papatheodoridis G.; Paruk I.; Patel K.; Macedo M.P.; Penha-Gonçalves C.; Figueroa M.P.; Hofmann W.P.; Sarin S.K.; Petta S.; de Oliveira C.P.M.S.; Puri P.; Pan C.Q.; Rac M.; Ralston J.; Ramji A.; Razavi H.; Alvares-da-Silva M.R.; Roberts S.; Loomba R.; Roden M.; Rose T.; Rouabhia S.; Rovere-Querini P.; Rowe I.A.; Sadirova S.; Salupere R.; Saparbu T.; Sayegh R.; Sebastiani G.; Miller V.; Seki Y.; Selmo J.; Serme A.K.; Shaw J.E.; Shenoy T.; Sheron N.; Shibolet O.; Silva M.; Skrypnyk I.; Socha P.; Newsome P.N.; Soriano J.; Spearman C.W.; Sridharan K.; Suárez J.J.; Sheriff D.S.; Sung K.-C.; Swain M.; Tacke F.; Taheri S.; Tan S.-S.; Ninburg M.; Tapper E.B.; Yki-Järvinen H.; Thiele M.; Shawa I.T.; Tolmane I.; Torres E.A.; Trauner M.; Treeprasertsuk S.; Turcanu A.; Valantinas J.; Ocama P.; Vesterhus M.; Waked I.; Wild S.H.; Willemse J.; Wong R.J.; Xanthakos S.; Young D.Y.; Yu M.-L.; Zheng K.I.; Zeybel M.; Ratziu V.; Zheng M.-H.; the NAFLD Consensus Consortium; Rinella M.; Romero D.; Romero-Gómez M.; Schattenberg J.M.; Tsochatzis E.A.; Valenti L.; Wong V.W.-S.; Yilmaz Y.; Younossi Z.M.; Zelber-Sagi S.; Åberg F.; Adams L.; Khatry M.S.A.; Naamani K.A.; Murillo O.A.; Allen A.M.; Alnaser F.; Alqahtani S.A.; Alswat K.; Alvaro D.; Andrade R.J.; Arrese M.; Awuku Y.A.; Ayesha M.; Baatarkhuu O.; Bakieva S.; Basu R.; Bataller R.; Bedri S.; Bosi E.; Bourliere M.; Bruha R.; Bugianesi E.; Burra P.; Buti M.; Byrne C.D.; Calleja J.L.; Carrieri P.; Carter F.; Fernandez M.I.C.; Castillo-Lopez G.; Castro-Narro G.E.; Chan H.L.Y.; Chan W.-K.; Chang Y.; Colombo M.; Coppell K.J.; Corey K.; Craxi A.; Cryer D.; Dassanayake A.; Martins A.A.S.; de Ledinghen V.; DelPrato S.; Demaio A.; Desalegn H.; Dillon J.; Duseja A.; Dorairaj P.; Ekstedt M.; El Kassas M.; Elsanousi O.M.; Esmat G.; Fan J.-G.; Farpour-Lambert N.; Flisiak R.; Fouad Y.; Fuchs M.; Gani R.A.; Gerber L.; Ghazinyan H.; Gheorghe L.; Goh G.B.-B.; Grønbæk H.; Gulnara A.; Hamid S.; Hebditch V. | Nature Reviews Gastroenterology and Hepatology | 328 | 283 | |
5 | 2021 | Mining Gut Microbiota From Bariatric Surgery for MAFLD | WEI-KAI WU ; Chen, Yi-Hsun; PO-CHU LEE ; PO-JEN YANG ; CHIN-CHEN CHANG ; KAO-LANG LIU ; CHENG-CHIH HSU ; Huang, Chi-Chang; Chuang, Hsiao-Li; Sheen, Lee-Yan; CHUN-JEN LIU ; MING-SHIANG WU | Frontiers in endocrinology | 6 | 5 | |
6 | 2021 | Molecular mechanisms and animal models of HBV-related hepatocellular carcinoma: With emphasis on metastatic tumor antigen 1 | Li Y.-T.; Wu H.-L.; CHUN-JEN LIU | International Journal of Molecular Sciences | 2 | 1 | |
7 | 2020 | Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges ahead | CHUN-JEN LIU ; PEI-JER CHEN | Viruses | 25 | 19 | |
8 | 2020 | Hepatitis C virus and hepatitis B virus co-infection | Shih Y.-F.; CHUN-JEN LIU | Viruses | 25 | 22 | |
9 | 2018 | Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment | Wong V.W.-S.; Chan W.-K.; Chitturi S.; Chawla Y.; Dan Y.Y.; Duseja A.; Fan J.; Goh K.-L.; Hamaguchi M.; Hashimoto E.; Kim S.U.; Lesmana L.A.; Lin Y.-C.; CHUN-JEN LIU ; YEN-HSUAN NI ; Sollano J.; Wong S.K.-H.; Wong G.L.-H.; Chan H.L.-Y.; Farrell G. | Journal of Gastroenterology and Hepatology (Australia) | 336 | 303 | |
10 | 2018 | The Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups | Chitturi S.; Wong V.W.-S.; Chan W.-K.; Wong G.L.-H.; Wong S.K.-H.; Sollano J.; YEN-HSUAN NI ; CHUN-JEN LIU ; Lin Y.-C.; Lesmana L.A.; Kim S.U.; Hashimoto E.; Hamaguchi M.; Goh K.-L.; Fan J.; Duseja A.; Dan Y.Y.; Chawla Y.; Farrell G.; Chan H.L.-Y. | Journal of Gastroenterology and Hepatology (Australia) | 118 | 97 | |
11 | 2017 | Combination therapy for chronic hepatitis B: Current updates and perspectives | TUNG-HUNG SU ; CHUN-JEN LIU | Gut and Liver | 19 | 15 | |
12 | 2016 | Asian consensus on the relationship between obesity and gastrointestinal and liver diseases | Koh J.C.; Loo W.M.; Goh K.L.; Sugano K.; Chan W.K.; Chiu W.Y.P.; Choi M.-G.; Gonlachanvit S.; Lee W.-J.; Lee W.J.J.; Lee Y.Y.; Lesmana L.A.; Li Y.-M.; CHUN-JEN LIU ; Matsuura B.; Nakajima A.; Ng E.K.W.; Sollano J.D.; Wong S.K.H.; Wong V.W.S.; Yang Y.; Ho K.Y.; Dan Y.Y. | Journal of Gastroenterology and Hepatology (Australia) | 45 | 39 | |
13 | 2016 | Perspectives on dual hepatitis B and C infection in Taiwan | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; TAI-CHUNG TSENG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 13 | 12 | |
14 | 2014 | Molecular mechanism and treatment of viral hepatitis-related liver fibrosis | TUNG-HUNG SU ; JIA-HORNG KAO ; CHUN-JEN LIU | International Journal of Molecular Sciences | 57 | 52 | |
15 | 2014 | Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues | CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 21 | 17 | |
16 | 2013 | Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 43 | 35 | |
17 | 2013 | Global perspective on the natural history of chronic hepatitis B: Role of hepatitis B virus genotypes A to J | CHUN-JEN LIU ; JIA-HORNG KAO | Seminars in Liver Disease | 141 | 125 | |
18 | 2012 | Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals | CHUN-JEN LIU ; Hsu C.-S.; JIA-HORNG KAO | Journal of Internal Medicine of Taiwan | 1 | ||
19 | 2010 | Implications of hepatitis B virus genomic variations on treatment outcomes | TAI-CHUNG TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO | Current Pharmacogenomics and Personalized Medicine | 5 | 0 | |
20 | 2009 | Dual chronic hepatitis B virus and hepatitis C virus infection | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology International | 43 | 37 | |
21 | 2008 | Genetic variability of hepatitis B virus and response to antiviral therapy | CHUN-JEN LIU ; JIA-HORNG KAO | Antiviral Therapy | 40 | 28 | |
22 | 2008 | Viral hepatocarcinogenesis: From infection to cancer | Tan A.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; Cheung C.; PEI-JER CHEN | Liver International | 102 | 84 | |
23 | 2007 | Hepatitis B virus genotype: What should the clinician know? | CHUN-JEN LIU ; JIA-HORNG KAO | Current Hepatitis Reports | 6 | 0 | |
24 | 2007 | Hepatitis B virus-related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factors | CHUN-JEN LIU ; JIA-HORNG KAO | Journal of the Chinese Medical Association | 71 | 0 | |
25 | 2006 | Natural course and treatment of hepatitis D virus infection | Hsieh T.-H.; CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of the Formosan Medical Association | 44 | 39 | |
26 | 2006 | Pegylated interferons for the treatment of chronic hepatitis B. | CHUN-JEN LIU ; JIA-HORNG KAO | Recent patents on anti-infective drug discovery | 5 | 0 | |
27 | 2005 | Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections | CHUN-JEN LIU ; JYH-MING LIOU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of the Formosan Medical Association | 45 | 36 | |
28 | 2005 | Therapeutic implications of hepatitis B virus genotypes | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 108 | 82 |